Bas D. Koster

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation

T. D. de Gruijl, K. Jooss, S. Lougheed, 2022, Science Immunology.

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

T. D. de Gruijl, E. Hooijberg, S. Santegoets, 2019, Cancer Immunology, Immunotherapy.